Results 151 to 160 of about 9,051 (207)

Safety evaluation of inactivated poliomyelitis vaccine. [PDF]

open access: yesHum Vaccin Immunother
Yan D   +9 more
europepmc   +1 more source

Optimizing preparedness and response for circulating vaccine derived poliovirus (cVDPV) outbreaks in the Eastern Mediterranean Region with a particular focus on cVDPV2. [PDF]

open access: yesFront Public Health
Haddad N   +9 more
europepmc   +1 more source

Vaccination with Inactivated Poliovirus Vaccine and Oral Poliovirus Vaccine in Denmark

Clinical Infectious Diseases, 1984
In Denmark a polio vaccination program including both inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine ( OPV ) has been in use since 1968. Three injections of IPV are given when the children are five, six, and 15 months of age. Subsequently, three vaccinations with trivalent OPV are administered at the age of three, four, and five years.
H, von Magnus, I, Petersen
openaire   +2 more sources

Comparison of Inactivated Poliovirus Vaccine and Oral Poliovirus Vaccine Programs in Israel

Clinical Infectious Diseases, 1984
In spite of high vaccination coverage, paralytic poliomyelitis still occurs in Israel, either in sporadic form in the urban area or in small outbreaks in the rural, non-Jewish segment. At high risk are mainly very young infants, not yet protected by poliovirus vaccine and children who have failed to seroconvert after a full course of oral poliovirus ...
T A, Swartz   +4 more
openaire   +2 more sources

Oral poliovirus vaccination and pregnancy complications

Acta Obstetricia et Gynecologica Scandinavica, 1995
Background. To determine whether the effect of live attenuated oral polio virus vaccine given to pregnant women increases pregnancy complications.Methods. A study of women who had been vaccinated against poliovirus during a national vaccination campaign and who had delivered by cesarean section in three obstetrical hospitals in southern Finland.
T, Harjulehto-Mervaala   +4 more
openaire   +2 more sources

Efficacy and safety of oral poliovirus vaccine and inactivated poliovirus vaccine

Pediatric Infectious Disease, 1991
Inactivated poliovirus vaccine (IPV) is the vaccine of choice for protection against paralytic poliomyelitis provided that it is used within the context of a program to increase and sustain the level of uptake to as close to 100% as possible. This means targeting the disadvantaged in society as well as those who have their own pediatrician. The reasons
openaire   +2 more sources

Sequential Use of Inactivated Poliovirus Vaccine followed by Oral Poliovirus Vaccine in Oman

Journal of Infectious Diseases, 1997
Seroprevalence and geometric mean titers (GMTs) were compared at 6 and 10 months after vaccination with monovalent type 1 oral poliovirus vaccine (OPV) at 6 months and trivalent OPV at 7 and 9 months. Group 1 had received 4 doses of OPV, group 2 OPV at birth and 3 doses of OPV and inactivated poliovirus vaccine (IPV), and group 3 placebo at birth and 3
R W, Sutter   +9 more
openaire   +2 more sources

Immunization with Oral Poliovirus Vaccine in China

Clinical Infectious Diseases, 1984
China began to produce oral, live poliovirus vaccine ( OPV ) in 1960. During 1960-1964, OPV was introduced in major cities only and subsequently was used throughout the country. Since that time the incidence of poliomyelitis has dropped dramatically, and the percentage of the healthy population with antibody has clearly risen.
openaire   +3 more sources

Home - About - Disclaimer - Privacy